Completed
A Phase 1 Safety Study of Single and Repeated Doses of JSM6427 (Intravitreal Injection) to Treat AMD
NCT00536016
- Conditions
- Eye Diseases, Macular Degeneration, Retinal Degeneration, +1 more
- Locations
-
- Retina Vitreous Associates Medical Group Beverly Hills, California, United States
- Ophthalmic Consultants of Boston Boston, Massachusetts, United States
- William Beaumont Research Institute Royal Oak, Michigan, United States
- Dean McGee Eye Institute Oklahoma City, Oklahoma, United States